SPY339.39-6.39 -1.85%
DIA277.00-6.34 -2.24%
IXIC11,358.94-189.35 -1.64%

JP Morgan Downgrades Intersect ENT to Neutral, Announces $19 Price Target

JP Morgan analyst Robert Marcus downgrades Intersect ENT (NASDAQ:XENT) from Overweight to Neutral and announces $19 price target.

· 10/08/2020 06:09
JP Morgan analyst Robert Marcus downgrades Intersect ENT (NASDAQ:XENT) from Overweight to Neutral and announces $19 price target.